Shockwave Medical
  • Technology
    • Challenges of Calcium
    • Intravascular Lithotripsy (IVL)
    • IVL Mechanism of Action
  • Clinicians
    • USA
    • Peripheral
      reimbursement Peripheral Reimbursement
      • Pre-TAVI
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • reimbursement Peripheral Reimbursement
    • Coronary
      reimbursement Coronary Reimbursement
    • reimbursement Coronary Reimbursement
    • Transfemoral Access
      • Pre-TAVR
      • Pre-EVAR/TEVAR
    • International
    • Peripheral
      • Pre-TAVR
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • Coronary
      • CAD Case Library
      • Clinical Evidence
        • CAD I
        • CAD II
        • CAD III
      • Product Specs & Resources
        • Shockwave C2
    • Transfemoral Access
      • Pre-TAVI
      • Pre-EVAR/TEVAR
  • Education
    • Calcium IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary IVL Reimbursement
  • Investors
    • Overview
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
  • About
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Home Education Blog
catalyst_logo

Welcome to The Catalyst

Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.

ico email Connect

ChalkTalk: SWAV CEO on “Most Innovative Companies” in Fast Company

Based on Shockwave’s recognition on Fast Company’s 2022 list of the World’s Most Innovative...

Read More

IVL in Hospitals with No Surgical Backup with Dr. B. Clay Sizemore

Dr. B. Clay Sizemore, Interventional Cardiologist at Cardiovascular Consultants of South Georgia,...

Read More

Disrupt CAD Pooled Gender Analysis Published in First Edition of JSCAI

Disrupt CAD Pooled Gender Analysis is now in published in JSCAI - the new journal of the Society...

Read More

Disrupt CAD III 1yr Data Published in First Edition of JSCAI

The one-year Disrupt CAD III data has been published in JSCAI – the new journal of the Society for...

Read More

Keep Your Finger on the Pulse: Q4 2021 Recap Newsletter

2021 was Shockwave’s best year yet! Although it brought challenges, with it came immense...

Read More

Expanding the Boundaries of Transfemoral Access in TAVI

Alternative access strategies in TAVI are prone to higher complication rates when compared to...

Read More

The Economics of Shockwave with Dr. Margaret McEntegart

Dr. Margaret McEntegart, Consultant Interventional Cardiologist at West of Scotland Heart and Lung...

Read More

Cracking Calcium at AICT-AsiaPCR 2021

For the first time, Shockwave Medical participated in ASIA-PCR, which was entirely virtual because...

Read More

2022 Medicare Reimbursement Updates

Great news!  The Centers for Medicare and Medicaid Services (CMS) has increased payment for...

Read More

ChalkTalk: New Insights from Coronary IVL Data at TCT21

In the latest ChalkTalk podcast, we’re going to listen in on a sponsored discussion that took place...

Read More
< Prev 1 2 3 4 5 ... 12 Next >
Topics
  • CAD Applications - Bifurcations
  • CAD Applications - Eccentric Lesions
  • Calcium Corner
  • ChalkTalk Podcast
  • Clinical Corner with Dr. Keith Dawkins
  • Clinical Corner with SW
  • Coronary Cases
  • Coronary Clinical Data
  • Coronary Conferences
  • Coronary IVL
  • Coronary IVL - U.S.
  • DISRUPT CAD
  • DISRUPT PAD
  • Insider
  • IVL Case
  • IVL Technology
  • Medical Meetings
  • PAD Applications - BTK
  • PAD Applications - CLI
  • PAD Applications - EVAR
  • PAD Applications - Iliac
  • PAD Applications - TAVR Access
  • PAD Applications - TEVAR
  • Peripheral Cases
  • Peripheral Clinical Data
  • Peripheral Conferences
  • Peripheral IVL
  • PulsePoint Newsletter
  • Q&A with Uday
  • Shockwave Behind-the-Scenes
  • Shockwave Breaking News
  • Shockwave C2
  • Shockwave M5
  • Shockwave S4
  • ShockwaveM5+
  • SWAV News

ChalkTalk: SWAV CEO on “Most Innovative Companies” in Fast Company

Posted by Michelle Revell on Mar 16, 2022 9:30:29 AM
  • Tweet

Based on Shockwave’s recognition on Fast Company’s 2022 list of the World’s Most Innovative Companies in the medical device sector for “bringing good vibrations to heart procedures,” we sat down with Shockwave CEO Doug Godshall for a Q&A to discuss how innovation is fostered at SWAV and why continual innovation is imperative to the future success of the company.

 

You can also read more about the honor in the company’s press release, in which Doug is quoted saying, “Shockwave Medical was founded with innovation at our core…not only for pioneering revolutionary and proprietary IVL technology, but also for the ways that innovation permeates every aspect of our business. We are continually evolving and transforming how we do things as we seek to astound our customers with life changing products for the treatment of calcified cardiovascular disease.”

 

 

 

Read More
0 Comments Click here to read/write comments

Topics: Shockwave Behind-the-Scenes, Coronary IVL, Peripheral IVL, IVL Technology, ChalkTalk Podcast

IVL in Hospitals with No Surgical Backup with Dr. B. Clay Sizemore

Posted by Emma Miller on Feb 17, 2022 3:26:52 PM
  • Tweet

Dr. B. Clay Sizemore, Interventional Cardiologist at Cardiovascular Consultants of South Georgia, Thomasville, GA speaks about his experience with coronary IVL in a no surgical backup hospital, discussing his patient selection criteria, importance of same day discharge and how IVL fits well into this strategy, thereby allowing the treatment of previously undilatable calcified lesions and minimizing the risk of patient transfer and procedure staging.

 

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, Coronary Cases, Shockwave C2, Coronary IVL - U.S., Calcium Corner

Disrupt CAD Pooled Gender Analysis Published in First Edition of JSCAI

Posted by Emma Miller on Feb 14, 2022 5:22:51 PM
  • Tweet

Disrupt CAD Pooled Gender Analysis is now in published in JSCAI - the new journal of the Society for Cardiovascular Angiography & Interventions. Read the JSCAI publication here: https://www.jscai.org/article/S2772-9303(21)00011-9/fulltext

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

Disrupt CAD III 1yr Data Published in First Edition of JSCAI

Posted by Emma Miller on Feb 14, 2022 5:19:41 PM
  • Tweet

The one-year Disrupt CAD III data has been published in JSCAI – the new journal of the Society for Cardiovascular Angiography & Interventions. The new data from Disrupt CAD III confirm the consistency of the excellent safety and effectiveness outcomes at 30 days out to one year.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

Keep Your Finger on the Pulse: Q4 2021 Recap Newsletter

Posted by Michelle Revell on Feb 10, 2022 2:52:28 PM
  • Tweet

2021 was Shockwave’s best year yet! Although it brought challenges, with it came immense opportunities which allowed us to grow and exceed expectations. As we push on into 2022, we are excited for what the year will bring but most importantly, for the opportunities to continue to help improve patient outcomes across the globe. But before we get started, let’s review the highlights of last quarter. We released four data releases, including our 1-year results of our Coronary IVL pivotal study at TCT this year, making it a monumental event. We had some exciting peer-reviewed publications come out, enrolled the first patient in the Disrupt BTK II Study, and much more. Read the latest PulsePoint for all the updates!

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, Peripheral IVL, IVL Technology, Coronary Cases, Peripheral Cases, Shockwave C2, Shockwave M5, Shockwave S4, PulsePoint Newsletter, Coronary IVL - U.S.

Expanding the Boundaries of Transfemoral Access in TAVI

Posted by Emma Miller on Feb 9, 2022 6:17:11 PM
  • Tweet

Alternative access strategies in TAVI are prone to higher complication rates when compared to transfemoral access. This leads to the question; should physicians tackle difficult transfemoral over alternative access?

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, Peripheral Cases, Peripheral Conferences, Peripheral Clinical Data

The Economics of Shockwave with Dr. Margaret McEntegart

Posted by Emma Miller on Feb 2, 2022 11:07:34 AM
  • Tweet

Dr. Margaret McEntegart, Consultant Interventional Cardiologist at West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital and Honorary Associate Clinical Professor, University of Glasgow, Glasgow, United Kingdom speaks about her experience with coronary IVL including practice-changing findings from her research comparing costs and resource utilization of rotational atherectomy vs. coronary Intravascular Lithotripsy.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, Coronary Cases, Shockwave C2, Coronary IVL - U.S., Calcium Corner

Cracking Calcium at AICT-AsiaPCR 2021

Posted by Emma Miller on Jan 13, 2022 4:57:37 PM
  • Tweet

For the first time, Shockwave Medical participated in ASIA-PCR, which was entirely virtual because of the ongoing COVID-19 pandemic. Watch our joint symposium with Abiomed entitled: “THE CHALLENGES OF COMPLEX PCI TREATMENT: Mechanical support in CHIP patients and IVL for calcified coronary disease”.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

2022 Medicare Reimbursement Updates

Posted by Emma Miller on Jan 10, 2022 2:57:59 PM
  • Tweet

Great news!  The Centers for Medicare and Medicaid Services (CMS) has increased payment for peripheral IVL procedures.  The increases apply to procedures performed in anatomical locations above the knee in a hospital outpatient setting.  The changes go into effect on January 1, 2022.  

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, Peripheral Cases, Peripheral Clinical Data

ChalkTalk: New Insights from Coronary IVL Data at TCT21

Posted by Michelle Revell on Dec 17, 2021 8:00:38 AM
  • Tweet

In the latest ChalkTalk podcast, we’re going to listen in on a sponsored discussion that took place with TCTMD during TCT21 about new insights on the latest Coronary IVL data that was presented during the meeting with Drs. Ajay Kirtane, Alexandra Lansky, Matthew Price, and Ziad Ali. Hope you enjoy the conversation and for more information on the data, please visit LetsGetCracking.com.

Read More
0 Comments Click here to read/write comments

Topics: Shockwave Behind-the-Scenes, Coronary IVL, Peripheral IVL, IVL Technology, ChalkTalk Podcast

Previous All posts Next

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin with Shockwave IVL Today

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

info@shockwavemedical.com

  • Technology
    • Challenges of Calcium
  • Applications
    • US
    • Peripheral
    • Coronary
    • TF Access
    • International
    • Peripheral
    • Coronary
    • TF Access
  • Education
    • Ca++ IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary Reimbursement
  • Investors
  • About Us
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Follow us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

  • Privacy Policy
  • ISI
  • Patents

© 2022 Shockwave Medical Inc. All rights reserved. | SPL 63081 Rev. A